Billings Clinic
Especially For:

Clinical Trials

Title   Amyloidosis In treated and Ineligible for Stem Cell Transplant
Description   CTSU E4A08 A Randomized Phase III trial of Melphalan and Dexamethasone vs Bortezomib, Melphalan and Dexamethasone for patients with Untreated Systemic Light-chain Amyloidosis who are Ineligible for Stem Cell Transplantation
IRB Number   CTSU E4A08
Category   Myeloma
Inclusion/Notes   18 years old or older
measurable disease without hypercalcemia or lytic bone lesions
Symptomatic organ involvement
Status   CLOSED
Start Date   11/11/2011
Principal Investigator (PI)   Jorge Nieva, MD
Physician Profile   Hematology/Oncology
Contact Name   Linda Allen, RN
Contact Email   lallen@billingsclinic.org
Phone   (406) 435-7484
Alternate Phone   (406) 435-7480
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.